STRATEC SE SBS
XETR · Germany · Health Technology
€21.65-0.35 (-1.59%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Stratec SE (XTER:SBS) narrows H1 revenue gap with a 15.4% surge in systems revenue and a dramatic free cash flow turnaround, while navigating supply chain risks and a soft consumables market.
Stratec (ETR:SBS) said its second-quarter performance improved significantly from a weak start to 2026, helping narrow its year-on-year sales and earnings gap in the first half. The company maintained its full-year guidance despite lower demand for service parts and consumables and an expectation th
BIRKENFELD, GERMANY - June 23, 2026 (NEWMEDIAWIRE) - Shareholders at today's Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard) approved all agenda items submitted for resolution for resolution with clear majorities. As propose...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.